Intern, Commercial Financial Planning & Analysis : June - August 2026 (Hybrid)

Intern - Financial Accounting And Analysis

The intern in this position will participate in roles involving financial accounting and analysis, as well as commercial finance.

Responsibilities :

• Participate in projects to streamline and improve functioning of Commercial FP&A US Team.
• Support financial planning and analysis functions related to budgeting / forecasting.
• Other projects as periodically assigned.
• Assist with sales reporting and analysis.
• Other common tasks include analysis of financial questions and problems (i.e. Regression and Trend Analysis), problem solving, active business partnering and developing innovative methods to improve job metrics and processes.

Education and Experience :

Minimum Requirements :

Preferred Skills & Competencies :

The US base salary range for this full-time position is $25.00 - $34.00. Our salary ranges are determined by role, level, and location. The range displayed on each job posting reflects the minimum and maximum target for new hire salaries for the position in the primary work location in the US. Within the range, individual pay is determined by work location and additional factors, including job-related skills, experience, and relevant education or training. Your Talent Acquisition Specialist can share more about the specific salary range for your preferred location during the hiring process. Please note that the compensation details listed in US role postings reflect the base salary only, and do not include bonus, equity, or benefits.

Insulet Corporation (NASDAQ : PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet's flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.

At Insulet Corporation all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.